Improving Acne Outcomes

Slides:

Advertisements

Similar presentations

Moderate-to-Severe Asthma Management

Advertisements

Chronic HCV Infection and CKD

Clinical Trials in IBD.

New Psoriasis Treatments

Psoriatic Arthritis.

Highlights From the 2017 Annual European MS Meeting

Why Gene Therapy for Hemophilia?

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States.

Relapsed/Refractory Follicular Lymphoma Conundrums

Exploring the Spectrum of Excessive Daytime Sleepiness

Pseudomonas Lung Infections in Cystic Fibrosis

Progression After Cancer Immunotherapy in Advanced NSCLC

Immune Reconstitution in MS:

Ask the Onychomycosis Expert, Part 2

Ask the Onychomycosis Expert, Part 1

Why Treat Seborrheic Keratosis?

Case Challenges in Chronic Migraine

Before and After: Patient Cases in Onychomycosis

Induction Chemotherapy for Patients With High-Risk or Secondary AML

Issues in the Management of Hemophilia: A Best Practice Series

Determining the Best Treatment Algorithm for Patients With Head and Neck Cancer.

Treat to Target in Gout.

BTK Inhibitors in Relapsed/Refractory Mantle Cell Lymphoma

The Resurgence of Topical Treatments Across a Spectrum of Psoriasis

Aligning Patients and Clinicians: Optimizing Outcomes in Metastatic NSCLC.

Chronic Idiopathic Urticaria

Treatment of Generalized Tonic-Clonic Seizures in the Modern Era

Emerging Targeted Agents for Relapsed/Refractory Non-Hodgkin Lymphoma

The Nurse View.

Expert Tips for Tackling Atopic Dermatitis in Pediatric Practice

The Evolving Role of Immunotherapy in NSCLC

Optimizing Management of Advanced Bladder Cancer

A Frontline Clinician's Guide to Managing Opioid-Induced Constipation

Improving Outcomes in OSA

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Next-Gen Psoriasis Therapies:

Evaluating Next-Generation BTK Inhibitors

Case Studies in Unresectable Hepatocellular Carcinoma

Gene Therapy: Past, Present, and Future

Emerging Atopic Dermatitis Treatments:

Essential Concepts in the Use of Immunotherapies in Bladder Cancer

CGRP Antibodies in Migraine

Perspectives on the Impact of Inflammation in OA

Optimizing Frontline Care for Older Patients With Multiple Myeloma

Best Practices in the Clinical Management of Motor Symptoms Associated With Huntington Disease.

New Recommendations on How to Stage Hidradenitis Suppurativa

New Data on Emerging Treatments for Psoriasis

When Is Biologic Therapy Appropriate for HS?

How to Select Therapy In Newly Diagnosed CLL

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Expert Perspectives on the Clinical Use of Immune Reconstitution vs Escalation Therapy for MS.

Developments in the Wet AMD Treatment Landscape

Advances in Immunotherapy for Peanut Allergy

Guide to Atopic Dermatitis

Clinical Pearls on Hot Topics in MS

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

The Burden of Psoriasis:

Evaluating BTK Inhibitors in CLL

Pregnancy in MS.

More Than Skin Deep.

Novel Concepts in the Management of RCC

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States, and data.

From Adjuvant to Metastatic in Melanoma

Why New Treatments for Hyperhidrosis Should Be on Your Radar

The Nurse View: Spotlight on Immune Checkpoint Inhibitors in Advanced Lung Cancer.

Optimizing Outcomes in mRCC: Finding the Balance of Immune Inhibition

Checkpoint Inhibitors in First-Line Advanced NSCLC

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Immune Checkpoint Inhibitors in Lung Cancer

Presentation transcript:

Improving Acne Outcomes

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US.

Acne

Classes of Acne Therapies

Case 1: Jeremy

Three Tips for Patients and Parents

Strategies for Improving Acne Treatment Adherence

Case 2: Alice

Case 3: Amanda

Topical Acne Treatments and Pregnancy

Oral Therapy Recommendations in Women With Acne Who Are Pregnant or Nursing

Case 4: Melissa

Tips For Treating Acne in People of Color

Case 5: Patricia

Combination Oral Contraceptives in Acne Treatment

Case 6: Benjamin

Topical Therapies: Onset of Action

Conclusions

Abbreviations